U.S. flag

An official website of the United States government

NM_133642.5(LARGE1):c.1903G>A (p.Ala635Thr) AND Muscular dystrophy-dystroglycanopathy type B6

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jul 24, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001303884.5

Allele description [Variation Report for NM_133642.5(LARGE1):c.1903G>A (p.Ala635Thr)]

NM_133642.5(LARGE1):c.1903G>A (p.Ala635Thr)

Gene:
LARGE1:LARGE xylosyl- and glucuronyltransferase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q12.3
Genomic location:
Preferred name:
NM_133642.5(LARGE1):c.1903G>A (p.Ala635Thr)
HGVS:
  • NC_000022.11:g.33277230C>T
  • NG_009929.2:g.648199G>A
  • NM_001362949.2:c.1903G>A
  • NM_001362951.2:c.1903G>A
  • NM_001362953.2:c.1903G>A
  • NM_001378624.1:c.1903G>A
  • NM_001378625.1:c.1903G>A
  • NM_001378626.1:c.1903G>A
  • NM_001378627.1:c.1756G>A
  • NM_001378628.1:c.1756G>A
  • NM_001378629.1:c.1747G>A
  • NM_001378630.1:c.1300G>A
  • NM_001378631.1:c.997G>A
  • NM_004737.7:c.1903G>A
  • NM_133642.5:c.1903G>AMANE SELECT
  • NP_001349878.1:p.Ala635Thr
  • NP_001349880.1:p.Ala635Thr
  • NP_001349882.1:p.Ala635Thr
  • NP_001365553.1:p.Ala635Thr
  • NP_001365554.1:p.Ala635Thr
  • NP_001365555.1:p.Ala635Thr
  • NP_001365556.1:p.Ala586Thr
  • NP_001365557.1:p.Ala586Thr
  • NP_001365558.1:p.Ala583Thr
  • NP_001365559.1:p.Ala434Thr
  • NP_001365560.1:p.Ala333Thr
  • NP_004728.1:p.Ala635Thr
  • NP_598397.1:p.Ala635Thr
  • LRG_856t1:c.1903G>A
  • LRG_856t2:c.1903G>A
  • LRG_856:g.648199G>A
  • LRG_856p1:p.Ala635Thr
  • LRG_856p2:p.Ala635Thr
  • NC_000022.10:g.33673216C>T
  • NM_004737.4:c.1903G>A
Protein change:
A333T
Links:
dbSNP: rs150325234
NCBI 1000 Genomes Browser:
rs150325234
Molecular consequence:
  • NM_001362949.2:c.1903G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001362951.2:c.1903G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001362953.2:c.1903G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378624.1:c.1903G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378625.1:c.1903G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378626.1:c.1903G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378627.1:c.1756G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378628.1:c.1756G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378629.1:c.1747G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378630.1:c.1300G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378631.1:c.997G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004737.7:c.1903G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133642.5:c.1903G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Muscular dystrophy-dystroglycanopathy type B6 (MDDGB6)
Synonyms:
MUSCULAR DYSTROPHY, CONGENITAL, LARGE-RELATED; MUSCULAR DYSTROPHY, CONGENITAL, TYPE 1D; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 6
Identifiers:
MONDO: MONDO:0012138; MedGen: C1837229; OMIM: 608840

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001493147Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jul 24, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV001493147.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 635 of the LARGE1 protein (p.Ala635Thr). This variant is present in population databases (rs150325234, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with LARGE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1006789). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 5, 2023